Glyco Discoveries, Inc
Publicly observedRaleigh, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Raleigh | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Glyco Discoveries, Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | PFBMHRWCG2G1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jul 2023Publicly observed
NIH SBIR/STTR award: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation
USD 786,273.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2023Publicly observed
NIH SBIR/STTR award: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation
USD 775,669.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.